GB Meka
Stocks to watch

WAT

Compare

WATERS CORP · Healthcare

$439.39
▼ 0.9%Close 2026-09-30

Live intraday price

Compare with our price levels

T2476.87
T1454.46
E1406.80
E3370.63
SL359.43

Close 2026-09-30: $439.39 · Levels are calculated once a day from the closing price; live prices come from TradingView (may be delayed at times)

Waiting▲ Leaning positiveWhale score 42

Not in the buy zone yet — needs to drop 7.4% · 1 whale recently bought

1 month
▲ 6.0%
3 months
▲ 16.2%
1 year
▲ 51.8%
Analyst target
$444.79 +1.2%

🎯 Trade plan by price level

Buy in 3 tranches in the buy zone · sell in 3 tranches at the targets · sell everything if the stop-loss breaks

Price levels and picks are calculated automatically with the same formula for every stock — for education only, not a recommendation to buy or sell. · How it's calculated

Buy zone
E1$406.80 -7.4%
E2$394.48 -10.2%
E3$370.63 -15.6%
Targets
T1$454.46 3.4%
T2$476.87 8.5%
T3$499.27 13.6%
Stop-loss
SL$359.43 -18.2%
Whale cost ~$326.46 -25.7%

Risk : reward 1 : 2.8Moves ~$11.20 a day

⚖️ Positives and risks

✓ Positives (5)
  • ●1 whale bought or added last quarter
  • ●Long-term uptrend (above a rising MA200)
  • ●Beat the market (S&P 500) by +30% over 6 months
  • ●Most analysts rate it Buy
  • ●Revenue up +113% year over year
! Risks (1)
  • ●3 whales sold or trimmed: Joel Greenblatt (trimmed), Bill Nygren (trimmed), Terry Smith (trimmed)

🕯️ Price chart

Green lines = buy zone E1–E3 · orange = targets T1–T3 · red = stop-loss · arrows = where the paper-trading bot bought/sold

🐋 Whales holding this stock

From each whale's latest quarterly filing

💬 User reviews

Rate and review this stock (sign-in required) — reviews don't affect the system's scores

Loading…

Ratings and comments are each user's own opinion. They don't affect the Smart-Money Score, signals, or price levels and are not investment advice · The average counts each person's latest rating, one vote per person

📰 Latest news

All news

🔬 Deep dive

For those who want the detailed numbers

Fundamentals
Market cap$43.2B
Next earnings2026-10-30
P/E (price to earnings)111.5
Forward P/E (on expected earnings)26.6
Revenue growth (YoY)+113.4%
Earnings growth (YoY)-
Net profit margin+3.6%
ROE+1.9%
Debt to equity (D/E)36%
Dividend yield-
Analyst targets (high / low)$515.00 / $349.00
Number of analysts24
Trend and technical indicators
Trend short / mid / longUptrend ↗ · Uptrend ↗ · Uptrend ↗
RSI65
MA50 / MA200$408.23 / $363.15
Distance from MA200+21.0%
MACDPositive
1-year high / low$447.98 / $282.77
vs. S&P 500 (6 months)+29.7%
Volume vs. average0.98×